We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
14 Jul 2020 - 14 Jul 2020
Virtual Venue
15 Jul 2020 - 19 Jul 2020
Virtual Venue

New Injection Technique Helps Repair Spinal Cord Injury

By HospiMedica International staff writers
Posted on 11 Feb 2020
Print article
Image: Injecting mesenchyml cells into the subpial space stimulates cell differentiation (Photo courtesy of Wikimedia)
Image: Injecting mesenchyml cells into the subpial space stimulates cell differentiation (Photo courtesy of Wikimedia)
A novel neural precursor cell (NSC) delivery technique employs single bolus cell injections into the subpial space to boost spinal cord recovery, according to a new study.

Developed by researchers at the University of California, San Diego (UCSD; USA), the Czech Academy of Sciences, (Libechov, Czech Republic), the University of the Ryukyus (Okinawa, Japan) and other institutions, the new technique injects NSCs into the subpial space--situated between the pial membrane and the superficial layers of the spinal cord—so that they can differentiate into multiple types of neural cells. In a study in immunodeficient rats, the researchers injected two boluses of human NSCs into the subpial space of the cervical and lumbar spinal cord, respectively.

The researchers then assessed the survival, distribution, and phenotype of the transplanted cells six to eight months later. Immunofluorescence staining and mRNA sequencing analysis demonstrated a near‐complete occupation of the spinal cord by injected cells, with the transplanted NSCs preferentially acquiring glial phenotypes. In the outermost layer of the spinal cord, the injected hNSCs differentiated into glia limitans‐forming astrocytes and expressed human‐specific superoxide dismutase and laminin. The study was published on January 29, 2020, in Stem Cells Translational Medicine.

“Current spinal cell delivery techniques involve direct needle injection into the spinal parenchyma, the primary cord of nerve fibers running through the vertebral column. As such, there is an inherent risk of spinal tissue injury or intraparechymal bleeding,” said corresponding author Professor Martin Marsala, MD, of UCSD. “The new technique is less invasive, depositing injected cells into the spinal subpial space. This injection technique allows the delivery of high cell numbers from a single injection. Injected cells acquire the functional properties consistent with surrounding host cells.”

According to the researchers, the data show that the subpial cell delivery technique is highly effective in populating the entire spinal cord with injected NSCs, accelerating and improving treatment potency in cell-replacement therapies for spinal neurodegenerative disorders in which a broad repopulation by glial cells, such as oligodendrocytes or astrocytes, is desired, such as in the treatment of amyotrophic lateral sclerosis (ALS), multiple sclerosis, or spinal cord injury.

Related Links:
University of California, San Diego
Czech Academy of Sciences
University of the Ryukyus



Print article

Channels

Business

view channel
Illustration

Omnia Health Live Unites Global Healthcare Community Through New Virtual Experience

Omnia Health Live, a virtual healthcare event, has brought the global healthcare community together on a scale never seen before through a new experience delivered entirely online. The virtual healthcare... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.